We are live on
!
Find out more
PHS
PFM Health Sciences Portfolio holdings
AUM
$1.1B
1-Year Est. Return
57.92%
This Fund
S&P 500
This Quarter
Est. Return
+12.48%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.63B
AUM Growth
-$655M
(-15%)
Cap. Flow
-$792M
Cap. Flow
% of AUM
-21.84%
Top 10 Holdings %
Top 10 Hldgs %
31.08%
Holding
113
New
24
Increased
24
Reduced
34
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$90.1M |
| 2 |
AerCap
AER
|
+$80M |
| 3 |
Pfizer
PFE
|
+$73.2M |
| 4 |
Illumina
ILMN
|
+$56.4M |
| 5 |
Equifax
EFX
|
+$54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$262M |
| 2 |
Vulcan Materials
VMC
|
+$208M |
| 3 |
Bausch Health
BHC
|
+$108M |
| 4 |
AGN
Allergan Inc
AGN
|
+$107M |
| 5 |
AGN
Allergan plc
AGN
|
+$82.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.17% |
| 2 | Industrials | 10.32% |
| 3 | Materials | 6.21% |
| 4 | Technology | 5.36% |
| 5 | Financials | 3.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Workday
WDAY
$41B
| $58.8M | 1.62% |
697,087
+441,794
| +173% | +$37.4M |
|
|
SAVE
27
DELISTED
Spirit Airlines, Inc.
SAVE
| $57.6M | 1.59% |
745,069
-104,402
| -12% | -$8.01M |
|
28
Apple
AAPL
$5T
| $53.6M | 1.48% |
+1,722,648
| New | +$52M |
|
29
Liberty Global Class C
LBTYK
$3.46B
| $52.1M | 1.44% |
1,293,629
+598,159
| +86% | +$23.7M |
|
30
Bristol-Myers Squibb
BMY
$129B
| $51.3M | 1.41% |
+795,346
| New | +$49.8M |
|
31
CF Industries
CF
$19.5B
| $50.9M | 1.4% |
897,020
+107,675
| +14% | +$6.42M |
|
32
Teva Pharmaceuticals
TEVA
$39.3B
| $49.8M | 1.37% |
798,697
-1,303,739
| -62% | -$75.8M |
|
|
RAD
33
DELISTED
Rite Aid Corporation
RAD
| $47.6M | 1.31% |
273,641
+75,538
| +38% | +$11.8M |
|
34
Dollar General
DG
$28B
| $47.5M | 1.31% |
630,049
-674,830
| -52% | -$47.7M |
|
|
VAR
35
DELISTED
Varian Medical Systems, Inc.
VAR
| $46.3M | 1.28% |
+560,578
| New | +$45M |
|
36
American Tower
AMT
$80.9B
| $45.3M | 1.25% |
+480,730
| New | +$46.7M |
|
37
Eagle Materials
EXP
$6.69B
| $38.5M | 1.06% |
+461,215
| New | +$35.9M |
|
|
AGN
38
DELISTED
Allergan plc
AGN
| $38M | 1.05% |
127,756
-290,271
| -69% | -$82.8M |
|
39
MGIC Investment
MTG
$6.53B
| $37.7M | 1.04% |
+3,914,266
| New | +$35.8M |
|
|
ZSPH
40
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $37.2M | 1.03% |
884,575
+383,626
| +77% | +$17.5M |
|
41
Karyopharm Therapeutics
KPTI
$155M
| $34.4M | 0.95% |
74,937
+18,248
| +32% | +$7.87M |
|
42
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
| $30.8M | 0.85% |
+340,305
| New | +$30.8M |
|
|
SCHW
43
Charles Schwab
SCHW
$184B
| $30.6M | 0.84% |
+1,004,371
| New | +$29.1M |
|
44
Masco
MAS
$14.6B
| $30.6M | 0.84% |
1,302,712
+533,592
| +69% | +$12.1M |
|
|
JUNO
45
DELISTED
Juno Therapeutics, Inc.
JUNO
| $30.5M | 0.84% |
514,585
-116,457
| -18% | -$5.65M |
|
|
RDUS
46
DELISTED
Radius Health, Inc.
RDUS
| $30M | 0.83% |
728,980
+726,056
| +24,831% | +$32.6M |
|
47
Williams-Sonoma
WSM
$27.3B
| $29.9M | 0.82% |
+750,332
| New | +$29.8M |
|
|
EXAS
48
DELISTED
Exact Sciences
EXAS
| $29.3M | 0.81% |
+1,331,742
| New | +$33.8M |
|
|
MDVN
49
DELISTED
MEDIVATION, INC.
MDVN
| $29.2M | 0.81% |
452,554
-82,970
| -15% | -$4.75M |
|
50
Accuray
ARAY
$28.2M
| $26.9M | 0.74% |
2,897,710
+2,063,425
| +247% | +$16.4M |
|
Similar funds
DAM
MAM
LCM
PRS
DAM
KCM
CF
MIA
PFM Health Sciences's Q1 2015 Portfolio in Review
As of Q1 2015, PFM Health Sciences held 113 positions worth $3.63B, down 15% from $4.28B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
PFM Health Sciences withdrew a net $792M in Q1 2015, closing 30 positions and reducing 34 holdings. Its most notable exit was Microsoft, an estimated $262M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 50% a quarter earlier, followed by Industrials and Materials.
Against the trend, PFM Health Sciences opened a new position in Jazz Pharmaceuticals worth $90.7M.
- PFM Health Sciences's largest Q1 2015 buy was Jazz Pharmaceuticals: 525,003 shares worth $90.7M.
- PFM Health Sciences added most to AerCap in Q1 2015, an estimated $80M increase.
- PFM Health Sciences's biggest Q1 2015 reduction was Vulcan Materials, cutting an estimated $208M.
- PFM Health Sciences fully exited Microsoft in Q1 2015, selling an estimated $262M.
- PFM Health Sciences's ten largest holdings make up 31% of its $3.63B portfolio in Q1 2015.
- PFM Health Sciences opened 24 new positions and closed 30 in Q1 2015.
- PFM Health Sciences's portfolio value fell 15% quarter-over-quarter to $3.63B.
Based on PFM Health Sciences's 13F filing for Q1 2015, filed 15 May 2015.